-+ 0.00%
-+ 0.00%
-+ 0.00%

FibroBiologics cell therapy preserves disc height in preclinical rabbit study

PUBT·10/19/2026 12:47:43
Listen to the news
FibroBiologics cell therapy preserves disc height in preclinical rabbit study
  • FibroBiologics presented preclinical degenerative disc disease findings at the North American Spine Society meeting on Oct. 15, 2026.
  • Fibroblast spheroid-derived chondrocyte spheroids preserved disc height better than other tested fibroblast treatments throughout a 12-week rabbit study.
  • All three fibroblast-based treatments improved disc height compared with controls following a single injection.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fibrobiologics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: DA74930) on October 19, 2026, and is solely responsible for the information contained therein.